0001600132-19-000016.txt : 20190104 0001600132-19-000016.hdr.sgml : 20190104 20190104163002 ACCESSION NUMBER: 0001600132-19-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190102 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fernandes Peter CENTRAL INDEX KEY: 0001642618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 19510466 MAIL ADDRESS: STREET 1: PERRYVILLE III CORPORATE PARK STREET 2: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_154663738293377.xml FORM 4 X0306 4 2019-01-02 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001642618 Fernandes Peter C/O BELLEROPHON THERAPEUTICS, INC. 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 0 1 0 0 Chief Regulatory & Safety Offr Stock Option (right to buy) 0.88 2019-01-02 4 A 0 12500 0 A 2029-01-02 Common Stock 12500.0 294790 D 1. This option was granted on January 2, 2019. This option vests in quarterly installments over a four-years period from the date of grant. /s/ Peter Fernandes 2019-01-02